Want to see HK:1450 full AI Analyst Report?
Century Sage Scientific Holdings Ltd (1450) Ratios
Century Sage Scientific Holdings Ltd Ratios
HK:1450's free cash flow for Q2 2026 was $120.02M. For the 2026 fiscal year, HK:1450's free cash flow was decreased by $-1.92M and operating cash flow was $121.94M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.71 | 1.50 | 1.29 | 1.11 | 1.12 |
| Quick Ratio | 1.71 | 0.96 | 1.03 | 0.85 | 0.80 |
| Cash Ratio | 0.90 | 0.24 | 0.37 | 0.16 | 0.20 |
| Solvency Ratio | 0.30 | 0.18 | 0.33 | 0.01 | -0.17 |
| Operating Cash Flow Ratio | 0.92 | -0.06 | 0.45 | -0.01 | 0.03 |
| Short-Term Operating Cash Flow Coverage | 5.97 | -0.13 | 1.71 | -0.02 | 0.05 |
| Net Current Asset Value | $ 250.20M | $ 194.03M | $ 74.41M | $ 9.01M | $ 10.43M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.27 | 0.22 | 0.34 | 0.43 |
| Debt-to-Equity Ratio | 0.18 | 0.60 | 0.57 | 1.62 | 2.78 |
| Debt-to-Capital Ratio | 0.15 | 0.38 | 0.36 | 0.62 | 0.74 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.05 | 0.11 | 0.16 | 0.28 |
| Financial Leverage Ratio | 1.78 | 2.21 | 2.54 | 4.79 | 6.42 |
| Debt Service Coverage Ratio | 2.02 | 0.41 | 1.31 | 0.07 | -0.11 |
| Interest Coverage Ratio | 31.83 | 8.30 | 10.23 | 0.37 | -3.81 |
| Debt to Market Cap | 0.04 | 0.16 | 0.07 | 0.06 | 0.18 |
| Interest Debt Per Share | 0.07 | 0.19 | 0.13 | 0.14 | 0.19 |
| Net Debt to EBITDA | -1.55 | 1.16 | 0.11 | 5.07 | -5.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.58% | 47.92% | 52.77% | 44.59% | 29.75% |
| EBIT Margin | 8.68% | 8.71% | 14.31% | 3.23% | -13.54% |
| EBITDA Margin | 11.06% | 9.59% | 17.15% | 4.64% | -11.10% |
| Operating Profit Margin | 8.51% | 8.55% | 13.57% | 1.27% | -27.29% |
| Pretax Profit Margin | 8.41% | 8.12% | 12.99% | -1.42% | -35.62% |
| Net Profit Margin | 6.07% | 6.53% | 11.12% | -2.16% | -30.38% |
| Continuous Operations Profit Margin | 6.03% | 5.78% | 10.61% | -3.85% | -33.89% |
| Net Income Per EBT | 72.17% | 80.49% | 85.62% | 152.03% | 85.30% |
| EBT Per EBIT | 98.81% | 94.96% | 95.70% | -112.48% | 130.51% |
| Return on Assets (ROA) | 9.53% | 8.84% | 15.83% | -2.06% | -14.58% |
| Return on Equity (ROE) | 16.96% | 19.50% | 40.15% | -9.87% | -93.64% |
| Return on Capital Employed (ROCE) | 22.68% | 23.60% | 42.08% | 4.18% | -47.63% |
| Return on Invested Capital (ROIC) | 14.26% | 11.36% | 25.15% | 2.12% | -19.72% |
| Return on Tangible Assets | 12.53% | 9.76% | 18.04% | -2.09% | -14.83% |
| Earnings Yield | 6.41% | 5.85% | 5.68% | -0.43% | -6.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.51 | 6.67 | 3.96 | 2.81 | 2.06 |
| Payables Turnover | 7.37 | 7.88 | 4.83 | 3.65 | 2.73 |
| Inventory Turnover | 2460.42 | 2.59 | 4.80 | 2.81 | 1.45 |
| Fixed Asset Turnover | 41.00 | 21.07 | 16.69 | 9.03 | 5.75 |
| Asset Turnover | 1.57 | 1.35 | 1.42 | 0.95 | 0.48 |
| Working Capital Turnover Ratio | 5.84 | 7.10 | 13.96 | 11.66 | 7.90 |
| Cash Conversion Cycle | -11.00 | 149.37 | 92.70 | 159.94 | 295.66 |
| Days of Sales Outstanding | 38.37 | 54.69 | 92.26 | 129.90 | 177.32 |
| Days of Inventory Outstanding | 0.15 | 141.02 | 76.03 | 129.97 | 252.16 |
| Days of Payables Outstanding | 49.51 | 46.34 | 75.59 | 99.92 | 133.83 |
| Operating Cycle | 38.52 | 195.71 | 168.29 | 259.86 | 429.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.26 | -0.02 | 0.13 | -0.00 | 0.01 |
| Free Cash Flow Per Share | 0.26 | -0.03 | 0.12 | -0.01 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | 53.36 | -1.52 | 11.55 | -0.43 | 21.04 |
| Capital Expenditure Coverage Ratio | 53.36 | -1.52 | 11.55 | -0.43 | 21.04 |
| Operating Cash Flow Coverage Ratio | 3.83 | -0.11 | 1.08 | -0.01 | 0.04 |
| Operating Cash Flow to Sales Ratio | 0.24 | -0.02 | 0.17 | -0.00 | 0.04 |
| Free Cash Flow Yield | 24.96% | -3.27% | 7.95% | -0.32% | 0.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 15.48 | 17.11 | 17.60 | -230.90 | -16.34 |
| Price-to-Sales (P/S) Ratio | 0.95 | 1.12 | 1.96 | 5.00 | 4.96 |
| Price-to-Book (P/B) Ratio | 2.65 | 3.34 | 7.07 | 22.79 | 15.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.01 | -30.59 | 12.58 | -308.15 | 135.40 |
| Price-to-Operating Cash Flow Ratio | 3.93 | -50.67 | 11.49 | -1020.13 | 128.97 |
| Price-to-Earnings Growth (PEG) Ratio | 1.15 | -0.57 | -0.01 | 2.68 | 0.43 |
| Enterprise Value Multiple | 7.01 | 12.82 | 11.51 | 112.64 | -50.16 |
| Enterprise Value | 1.15B | 1.54B | 2.12B | 2.23B | 1.13B |
| EV to EBITDA | 7.01 | 12.82 | 11.51 | 112.64 | -50.16 |
| EV to Sales | 0.78 | 1.23 | 1.97 | 5.23 | 5.57 |
| EV to Free Cash Flow | 3.28 | -33.64 | 12.69 | -322.69 | 151.89 |
| EV to Operating Cash Flow | 3.22 | -55.73 | 11.60 | -1068.25 | 144.67 |
| Tangible Book Value Per Share | 0.23 | 0.24 | 0.15 | 0.08 | 0.08 |
| Shareholders’ Equity Per Share | 0.39 | 0.30 | 0.22 | 0.08 | 0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.29 | 0.18 | -1.71 | 0.05 |
| Revenue Per Share | 1.10 | 0.91 | 0.78 | 0.37 | 0.19 |
| Net Income Per Share | 0.07 | 0.06 | 0.09 | -0.01 | -0.06 |
| Tax Burden | 0.72 | 0.80 | 0.86 | 1.52 | 0.85 |
| Interest Burden | 0.97 | 0.93 | 0.91 | -0.44 | 2.63 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.34 | 0.41 | 0.16 | 0.25 | 0.38 |
| Stock-Based Compensation to Revenue | 0.02 | 0.04 | 0.08 | 0.06 | 0.00 |
| Income Quality | 2.86 | -0.27 | 1.31 | 0.23 | -0.13 |
Currency in CNY
